A new study suggests that reducing high-fat dairy intake may help lower the risk of developing fatty liver disease.

Discover a new study that has examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in ...

MASLD diagnosis was associated with an increased risk for youth-onset type 2 diabetes among pediatric patients with obesity.

Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be ...

Metabolic risk factors and overweight or obesity increase the risk for MASLD and advanced fibrosis among older adults.

A recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Data on clinical outcomes in MASLD are lacking. This study’s goal was to provide a comprehensive meta-analysis of the ...

A recent study suggested that metabolic-associated steatohepatitis can be managed by a multifaceted approach that includes ...

Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...

Diagnostic challenges and underestimation in claims data affect accurate prevalence assessment of MASH and MASLD. Mathematical frameworks help adjust prevalence estimates, revealing higher true ...